DNA Chip Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

DNA Chip Research şirketinin toplam hissedar öz sermayesi ¥711.0M ve toplam borcu ¥0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥940.0M ve ¥229.0M dir.

Anahtar bilgiler

Borç/özkaynak oranı

JP¥0

Borç

Faiz karşılama oranı	n/a
Nakit	JP¥412.00m
Eşitlik	JP¥711.00m
Toplam yükümlülükler	JP¥229.00m
Toplam varlıklar	JP¥940.00m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 2397 'nin kısa vadeli varlıkları ( ¥623.0M ) kısa vadeli yükümlülüklerini ( ¥187.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: 2397 şirketinin kısa vadeli varlıkları ( ¥623.0M ) uzun vadeli yükümlülüklerini ( ¥42.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 2397 borçsuzdur.

Borcun Azaltılması: 2397 son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 2397 şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: 2397 serbest nakit akışı her yıl % 12 1.9 yıl yetecek nakit akışına sahip olacaktır.

DNA Chip Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

DNA Chip Research Inc. to Report Q2, 2025 Results on Nov 07, 2024

First quarter 2025 earnings released: JP¥2.96 loss per share (vs JP¥15.11 loss in 1Q 2024)

New major risk - Share price stability

Insufficient new directors

Full year 2024 earnings released: JP¥39.02 loss per share (vs JP¥61.70 loss in FY 2023)

DNA Chip Research Inc., Annual General Meeting, Jun 26, 2024

New minor risk - Shareholder dilution

DNA Chip Research Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Third quarter 2024 earnings released: JP¥11.97 loss per share (vs JP¥18.70 loss in 3Q 2023)

DNA Chip Research Inc. announced that it expects to receive ¥269.99972 million in funding from Mitsui Chemicals, Inc.

New minor risk - Share price stability

DNA Chip Research Inc. to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: JP¥10.24 loss per share (vs JP¥16.91 loss in 2Q 2023)

DNA Chip Research Inc. to Report Q2, 2024 Results on Nov 02, 2023

First quarter 2024 earnings released: JP¥15.11 loss per share (vs JP¥18.65 loss in 1Q 2023)

DNA Chip Research Inc. to Report Q1, 2024 Results on Jul 27, 2023

Full year 2023 earnings released: JP¥61.70 loss per share (vs JP¥23.15 loss in FY 2022)

DNA Chip Research Inc., Annual General Meeting, Jun 21, 2023

Third quarter 2023 earnings released: JP¥18.70 loss per share (vs JP¥6.74 loss in 3Q 2022)

DNA Chip Research Inc. announced that it expects to receive ¥279.99974 million in funding from Mitsui Chemicals, Inc.

DNA Chip Research Inc. to Report Q3, 2023 Results on Jan 24, 2023

Second quarter 2023 earnings released: JP¥16.91 loss per share (vs JP¥10.19 loss in 2Q 2022)

DNA Chip Research Inc. to Report Q2, 2023 Results on Oct 28, 2022

First quarter 2023 earnings released: JP¥18.65 loss per share (vs JP¥12.61 loss in 1Q 2022)

DNA Chip Research Inc. to Report Q1, 2023 Results on Jul 28, 2022

DNA Chip Research Inc., Annual General Meeting, Jun 22, 2022

Full year 2022 earnings released: JP¥23.15 loss per share (vs JP¥30.30 loss in FY 2021)

DNA Chip Research Inc. to Report Fiscal Year 2022 Results on Apr 28, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥10.19 loss per share (vs JP¥10.36 loss in 2Q 2021)

First quarter 2022 earnings released: JP¥12.61 loss per share (vs JP¥13.12 loss in 1Q 2021)

Full year 2021 earnings released: JP¥30.30 loss per share (vs JP¥25.15 loss in FY 2020)

DNA Chip Research Inc. to Report Fiscal Year 2021 Results on Apr 22, 2021

Third quarter 2021 earnings released: JP¥8.46 loss per share (vs JP¥11.40 loss in 3Q 2020)

Third quarter 2021 earnings released: JP¥8.46 loss per share

DNA Chip Research Inc. to Report Q3, 2021 Results on Jan 21, 2021

New 90-day low: JP¥644

New 90-day low: JP¥747

DNA Chip Research Inc. to Report Q2, 2021 Results on Oct 22, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin